Dr. Todd Golde is a Professor of Pharmacology and Chemical Biology and Neurology at Emory University. He is the Director of the Emory Center for Neurodegenerative Disease (CND) and associate director of the Emory ADRC. Dr. Golde has made significant contributions to the AD field. His work has provided seminal insights into various aspects of AD pathobiology and therapeutics including the role of Ab42, identification of g-secretase modulators, innate immune activation and targeted immunotherapies. Throughout his career Dr. Golde has emphasized collaborative science and has built and led interdisciplinary teams to address complex questions in neurodegenerative disease.
